Research and Clinical Insights From Baylor Scott & White Contribute to Impressive ACC Annual Scientific Session & Expo Agenda

The American College of Cardiology and the World Heart Federation's World Congress of Cardiology (WCC) bring members of the global cardiovascular community together for ACC.23/WCC, in New Orleans, Louisiana, March 4-6. The ACC.23/WCC Expo is the largest gathering of clinicians, researchers and innovative products and services providers under one roof, giving members of the cardiovascular community access to knowledge, resources and collaborative opportunities to help advance care options and improve outcomes for patients worldwide.

Baylor Scott & White Health clinicians and researchers will be involved in more than 70 presentations, scheduled talks, education sessions and panel discussions.

A snapshot of talks and presentations with Baylor Scott & White involvement can be found below. Additional details about the meeting can be found on the event website.

Click here to download


Featured Presentations And Sessions Highlighting Cardiovascular Research

Saturday, March 4, 2023

Left Ventricular Pseudoaneurysm: To Treat Or Not To Treat?

  • Author: Corry B. Sanford, MD - Baylor Scott & White Medical Center - Temple

  • Time: 10:45-11:30 a.m. CST

  • Abstract/Study Purpose: Left ventricular (LV) pseudoaneurysm, a rare complication of acute myocardial infarction (MI), occurs in less than 0.5%. Most present with non-specific symptoms such as chest pain and dyspnea, but some may remain asymptomatic. Although rare, they are prone to rupture and associated with increased mortality.

  • For More Information: Click Here

Beating The Odds: A Case Of Confirmed Global Ischemia With A Favorable Outcome

  • Author: Nicole M. Prescott, MD - Baylor Scott & White Medical Center – Temple

  • Time: 10:45-11:30 a.m. CST

  • Abstract/Study Purpose: Evidence of global ischemia (GI) on ECG is associated with a poor prognosis and increased mortality when compared with other ECG patterns.

  • For More Information: Click Here

Myocardial Infarction Stemming from an Occluded Left Subclavian Stent in a Post-CABG Patient: A Positive Outcome With Use Of Invasive Cardiac Support

  • Author: Christina V. Chanthanivong, MD – Baylor Scott & White All Saints Medical Center — Fort Worth

  • Time: 10:45-11:30 a.m.CST

  • Abstract/Study Purpose: Coronary-subclavian steal syndrome (CSSS) is a well-described phenomenon characterized by retrograde blood flow through a left internal mammary artery graft resulting in unbalanced myocardial infusion through the left anterior descending artery. A rare complication is acute anterior myocardial infarction.

  • For More Information: Click Here

Cardiovascular Care of Women in the Post-Dobbs Era

  • Panelist: Shelley Hall, MD – Baylor University Medical Center, part of Baylor Scott & White Health

  • Time: 11:45 a.m.- 12:15 p.m. CST

  • For More Information: Click Here

A Window Better Left Closed: Right Atrial Angiosarcoma Inducing Pericardial Effusion and Tamponade

  • Author: Adam Sundholm, MD – Baylor University Medical Center, part of Baylor Scott & White Health

  • Time: 12:45-1:30 p.m. CST

  • Abstract/Study Purpose: Cardiac angiosarcoma (CA) can induce pericardial effusion. Masses are often seen on initial non-invasive imaging. I present a right atrial (RA) CA leading to tamponade not seen until intra-operative transesophageal echocardiogram (TEE) during pericardial window (PW) with further characterization by cardiac MRI (cMRI).

  • For More Information: Click Here

Iatrogenic Ventricular Septal Defect (VSD) Treated With Amplatzer PFO Occluder Device Following Valve-In-Valve (VIV) TAVR

  • Author: Syed Siddiqullah, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 12:45-1:30 p.m. CST

  • Abstract/Study Purpose: The formation of iatrogenic VSD during TAVR is a rare complication requiring intervention in symptomatic patients.

  • For More Information: Click Here

Do You Need Antiplatelets and Anticoagulation for Heart Mate 3?

  • Author: Youssef Yaacoub, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 1:45-2:30 p.m. CST

  • Abstract/Study Purpose: Left ventricular assist devices (LVADs) are increasingly being used as a bridge to heart transplantation (BTT) and as a destination therapy (DT). Continuous-flow (CF) LVADs carry fewer complications and have better durability than the old pulsatile-flow LVADs. The 2012 AHA Scientific Statement and 2013 ISHLT guidelines recommend both antiplatelet and anticoagulants in CF-LVADs.

  • For More Information: Click Here

Nuclear Imaging

  • Author: Ingrid Hsiung, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 1:45-2:30 p.m. CST

  • Abstract/Study Purpose: Nuclear myocardial perfusion imaging (MPI) is used to risk stratify patients for coronary artery disease. False positives can arise due to various reasons, including diaphragmatic or breast attenuation. We present a case of unusual false positive nuclear stress test.

  • For More Information: Click Here

Management of Aortic Valve Disease in Non-Elderly Adults

  • Speaker: William Brinkman, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 2:21-2:26 p.m. CST

  • Case Scenario: Scenario III: DEBATE: PRO - Root Enlargement + SAVR

  • For More Information: Click Here

Waardenburg Syndrome: A Genetic Predisposition to Semilunar Valvular Disease

  • Author: Asim Mohiuddin, MD – Baylor University Medical Center, part of Baylor Scott & White Health

  • Time: 2:45-3:30 p.m. CST

  • Abstract/Study Purpose: Waardenburg syndrome (WS) is an autosomal dominant multigene disorder known to affect pigmented cells and cause hearing loss. Mutations involving  Pax3  deletion in mouse models are linked with abnormal semilunar valve morphology. Patients with underlying structural valvular abnormality are at an increased risk of infective endocarditis.

  • For More Information: Click Here

Diagnosis and Management of Myocardial Perforation During TAVI

  • Author: Ali-Reza Ghergherehchi, MD - Baylor Scott & White Medical Center – Temple

  • Time: 3:45-4:30 p.m. CST

  • Abstract/Study Purpose: Left ventricular perforation is a rare and serious complication of TAVI that requires immediate diagnosis and management.

  • For More Information: Click Here

A Mysterious Case of a Bidirectional Shunt with Eisenmenger Physiology and No Pulmonary Hypertension Successfully Treated with Transcatheter Closure of Atrial Septal Defect

  • Author: Mohammed Salih, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 3:45-4:30 p.m. CST

  • Abstract/Study Purpose: Atrial septal defect (ASD) is usually associated with a left-to-right shunt; however, when shunt reversal occurs, concern about Eisenmenger syndrome limited the treatment options. We present a case of a 64-year-old female who presented with refractory hypoxia with a subsequent diagnosis of a giant ASD and Epstein anomaly that was successfully treated with ASD closure.

  • For More Information: Click Here

Triclip For Severe Tricuspid Regurgitation After an Orthotopic Heart Transplant

  • Author: Kashmala Khan, MD – Baylor Scott & White Medical Center – Round Rock

  • Time: 3:45-4:30 p.m. CST

  • Abstract/Study Purpose: Tricuspid regurgitation (TR) as a result of damage to the tricuspid valve post endomyocardial biopsy (EMB) has been reported in patients who have had orthotopic heart transplant.

  • For More Information: Click Here

Successful Transcatheter Closure of Symptomatic Massive Coronary Artery Fistulas Presenting with Heart Failure Symptoms

  • Author: Mohammed Salih, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 3:45-4:30 p.m. CST

  • Abstract/Study Purpose: Coronary artery fistulas (CAF) are rare. We present two interesting cases of percutaneous closure of massive CAF presenting with heart failure symptoms.

  • For More Information: Click Here

Sunday, March 5, 2023

Session 667 - To PCI or Not to PCI: Challenges in Coronary Revascularization

  • Speaker: Michael J. Mack, MD – Baylor Scott & White Health

  • Time: 10:00-10:08 a.m. CST

  • Discussion: Left Main Debate: CABG All the Way!.

  • For More Information: Click Here

Utilizing Valvuloarterial Impedance to Improve Precision of Aortic Stenosis Quantification

  • Author: Jerry Fan, MD – Baylor Scott & White Medical Center – Temple

  • Time: 10:45-11:30 a.m. CST

  • Abstract/Study Purpose: Degenerative aortic stenosis (AS) is a valvular heart disease resulting in need for valve replacement. The timing of aortic valve replacement is dependent on valve area and flow metrics, which are determined by left ventricular (LV) afterload, myocardial compliance, and workload. Valvuloarterial impedance (Zva) is a useful tool that estimates global LV hemodynamic load which can alter the severity of AS.

  • For More Information: Click Here

A New Report on Utilizing Pioneer Plus Ivus Guided Re-entry Catheter Through Radial Access in Peripheral Cto Intervention With A Successful Technical And Clinical Outcome

  • Author: Mohammed Salih, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 10:45-11:30 a.m. CST

  • Abstract/Study Purpose: The use of Pioneer plus IVUS-guided re-entry catheter (PPIGRC) has been traditionally performed through femoral artery access to guide true lumen re-entry. Limited data are available for its use through radial artery access. We report a case of a 71-year-old male with severe claudication where PPIGRC was used through a right radial approach with successful revascularization.

  • For More Information: Click Here

Are We Creating a New Potential Problem with Prolonged Temporary Mechanical Support? Development of De Novo Anti-human Leukocyte Antigen Antibodies Production in a Patient Bridged By Impella 5.5 Device To Orthotopic Heart Transplantation

  • Author: Hira Shakoor – Baylor Scott & White Research Institute

  • Time: 11:45-11:55 a.m. CST

  • Abstract/Study Purpose: Little is known regarding the development of anti-human leukocyte antigen antibodies (HLAs) with the new Impella 5.5 as a bridge to transplantation.

  • For More Information: Click Here

SCAD Complicated by Cardiogenic Shock Requiring CABG

  • Author: Keerthana Pakanati, MD – Baylor Scott & White Medical Center – Round Rock

  • Time: 11:45 a.m. - 12:30 p.m. CST

  • Abstract/Study Purpose: Spontaneous coronary artery dissection (SCAD) is myocardial injury occurring as an epicardial coronary artery dissection in the absence of trauma or atherosclerosis. The incidence of cardiogenic shock is 2-3% in SCAD patients, but can increase to 25% in SCAD patients presenting with a STEMI. Treatment is often conservative due to revascularization risks. We present a case of a patient who presented with SCAD complicated by cardiogenic shock requiring a salvage coronary artery bypass graft (CABG) surgery.

  • For More Information: Click Here

The Off-Hour Effect in Patients with Cardiogenic Shock

  • Author: Shelley Hall, MD – Baylor University Medical Center, part of Baylor Scott & White Health

  • Time: 11:45 a.m. - 12:30 p.m. CST

  • Abstract/Study Purpose: The "off-hours effect" is a phenomenon where patients admitted overnight or on weekends have poorer outcomes, especially in acute severe conditions. Little is known about whether this effect influences outcomes in patients diagnosed with cardiogenic shock.

  • For More Information: Click Here

Cardiac Arrest and Severe Mitral Regurgitation: A MAD Story

  • Author: Gurjaspreet Bhattal, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 11:45 a.m. - 12:30 p.m. CST

  • Abstract/Study Purpose: Mitral annular disjunction (MAD) is often an underrecognized but significant risk factor in arrhythmogenic and malignant mitral valve prolapse (MVP) patients.

  • For More Information: Click Here

Acute Aortic Dissection In Turner Syndrome

  • Author: John Nguyen, MD – Baylor Scott & White Medical Center – Round Rock

  • Time: 12:45-1:30 p.m. CST

  • Abstract/Study Purpose: Turner syndrome is a chromosomal disorder characterized by partial or complete loss of an X chromosome. This leads to medical and developmental disorders, including short stature, premature ovarian failure and cardiac abnormalities. The most common cardiac abnormalities include bicuspid aortic valve (AV) and coarctation of the aorta, and these patients are at risk for progressive aortic root dilation and/or dissection. We present a case of aortic dissection in a patient with Turner syndrome.

  • For More Information: Click Here

Intraabdominal Abscesses Leading to Iliac Vein Compression Syndrome And Submassive Pulmonary Emboli

  • Author: Rahul Sawhney, DO – Baylor Scott & White The Heart Hospital – Plano

  • Time: 1:45-2:30 p.m. CST

  • Abstract/Study Purpose: Iliac vein compression syndrome (IVCS) is a syndrome in which the left common iliac vein is commonly compressed by the right iliac artery, however the compression can be from other causes. We report two cases of IVCS caused by intraabdominal abscesses and complicated by bilateral submassive pulmonary emboli.

  • For More Information: Click Here

Looks Like a Vegetation But It is Not Endocarditis

  • Author: Mica Alex, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 2:45-3:30 p.m. CST

  • Abstract/Study Purpose: Myxomas are the second most common primary cardiac tumor (PCT) but overall have a low incidence rate. They usually arise from the interatrial septum whereas infective endocarditis (IE) vegetations frequently develop where there is turbulent blood flow, i.e., on the atrial side of the atrioventricular valves.

  • For More Information: Click Here

Quadricuspid Aortic Valve And Advanced Imaging

  • Author: Mica Alex, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 3:45-4:30 p.m. CST

  • Abstract/Study Purpose: Quadricuspid aortic valve (QAV) is a rare congenital anomaly with an incidence rate less than 0.05%. QAV was previously diagnosed during surgery or in postmortem exam but now with more advanced imaging techniques, it is more reliably identified.

  • For More Information: Click Here

A Case of Primary Cardiac Undifferentiated Sarcoma Presenting As Non-ST Elevation Myocardial Infarction

  • Author: John Nguyen, MD – Baylor Scott & White Medical Center – Round Rock

  • Time: 3:45-4:30 p.m. CST

  • Abstract/Study Purpose: Primary cardiac sarcomas are extremely rare and aggressive. Despite a low prevalence, survival is between 1 to 2 years. The most commonly described sarcomas are angiosarcomas, rhabdomyosarcomas, fibrosarcomas, undifferentiated sarcomas, leiomyosarcomas, and synovial sarcomas. We describe a case of undifferentiated pleomorphic sarcoma who presented with non-ST elevation myocardial infarction.

  • For More Information: Click Here

Patterns of Cocaine-Induced Myocardial Necrosis on Cardiac MRI

  • Author: Olajide Buhari, MD – Baylor Scott & White Medical Center – Temple

  • Time: 3:45-4:30 p.m. CST

  • Abstract/Study Purpose: Cocaine is a potent sympathomimetic associated with adverse cardiac events such as myocardial infarction, necrosis, and dilated cardiomyopathy.

  • For More Information: Click Here

Diagnostic Dilemma In A Case of Serial Obstructions in an 84-Year-Old Female

  • Author: Youssef Yaacoub, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 3:45-4:30 p.m. CST

  • Abstract/Study Purpose: Sub-valvular aortic stenosis (AS) is a rare congenital heart defect. A discrete subaortic membrane is an uncommon cause of left ventricular outflow tract (LVOT) obstruction in patients of advanced age. We report a case of an 84-year-old woman with significant LVOT obstruction caused by a discrete membrane, mid-cavitary obstruction and aortic stenosis.

  • For More Information: Click Here

Quadricuspid Aortic Valve and Advanced Imaging

  • Author: Mica Alex, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 3:45-4:30 p.m. CST

  • Abstract/Study Purpose: Quadricuspid aortic valve (QAV) is a rare congenital anomaly with an incidence rate less than 0.05%. QAV was previously diagnosed during surgery or in postmortem exam but now with more advanced imaging techniques, it is more reliably identified.

  • For More Information: Click Here

Monday, March 6, 2023

Avoiding the Crash and Burn: How to Navigate Cardiogenic Shock

  • Co-Chair: Shelly Hall, MD – Baylor University Medical Center, part of Baylor Scott & White Health

  • Time: 8:30-9:45 a.m. CST

  • Summary: The twists and turns in navigating cardiogenic shock are growing more complex. In this session we focus on the entire journey of the cardiogenic shock patient, starting from diagnosis and management and ending with advanced decision-making considerations.

  • For More Information: Click Here

Percutaneous Closure Of Mitral Annuloplasty Ring Dehiscense Complicated By Severe Transvalvular Regurgitation Requiring Transcatheter Mitral Valve Replacement

  • Author: Hoang Nguyen, MD – Baylor Scott & White Medical Center – Round Rock

  • Time: 9:45-10:30 a.m. CST

  • Abstract/Study Purpose: Percutaneous interventions for patients with severe mitral regurgitation (MR) with prior mitral valve repair include edge-to-edge repair, transcatheter mitral valve replacement (TMVR), and catheter-based plugging with occluder devices. We present a case of a patient with mitral annuloplasty ring dehiscence who underwent percutaneous closure that was complicated by severe transvalvular MR requiring TMVR.

  • For More Information: Click Here

Desmoplakin Mutation Causing Arrhythmogenic Left Ventricular Cardiomyopathy

  • Author: Sarah Payne, MD – Baylor Scott & White Medical Center – Temple

  • Time: 9:45-10:30 a.m. CST

  • Abstract/Study Purpose: Desmoplakin (DSP) is a cardiac structural protein that links desmosomes to the intermediate filament. Mutation of genes encoding this protein leads to abnormal force transmission, myocardial fibrosis, and arrhythmogenic cardiomyopathy.

  • For More Information: Click Here

Late Presenting Severe Mitral Regurgitation Despite Revascularization Post-STEMI

  • Author: Ahmed Kazem, DO – Baylor Scott & White The Heart Hospital – Plano

  • Time: 9:45-10:30 a.m. CST

  • Abstract/Study Purpose: Mechanical complications due to myocardial infarction have declined recently given the availability of prompt care with percutaneous interventions. Due to the associated morbidity and mortality, having a high index of suspicion to identify and intervene is important. We present a case of a patient who developed acute severe mitral regurgitation (MR) and cardiogenic shock late in the post STEMI course — approximately 1 month post revascularization.

  • For More Information: Click Here

Master of Disguise: Pulmonary Vein Stenosis Mimicking a Pulmonary Embolism

  • Author: Rakushumimarika Harada, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 9:45-10:30 a.m. CST

  • Abstract/Study Purpose: Pulmonary vein stenosis (PVS) is a complication of atrial fibrillation ablation. A case of PVS presenting as a mimicker of a large pulmonary embolism (PE) is described.

  • For More Information: Click Here

More Than One Way To Skin A Cat – Percutaneous Mechanical Thrombectomy Via Transradial Access

  • Author: Ashkan Ahmadian-Tehrani, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 9:45-10:30 a.m. CST

  • Abstract/Study Purpose: Percutaneous thrombectomy devices are a valuable option in the treatment of thrombotic peripheral artery disease. Vascular access can sometimes be limited by disease location, severity and anatomy. This case demonstrates a novel approach to peripheral thrombectomy using the Truvic Prodigy mechanical thrombectomy device via transradial artery approach.

  • For More Information: Click Here

Elevated Early Donor Derived Cell Free DNA Levels In Sherpapak Cardiac Transport System Versus Ice Transportation

  • Author: Johanna Van Zyl – Baylor Scott & White Research Institute

  • Time: 10:45-10:55 a.m. CST

  • Abstract/Study Purpose: SherpaPak (SP) Cardiac Transport System is intended for static hypothermic preservation of hearts during transportation for transplantation. We aimed to determine if differences existed in donor derived cell free DNA (dd-cfDNA) using SP when compared with historical ice transportation.

  • For More Information: Click Here

Analysis of Procedure Volume and Outcomes of Surgical Aortic Valve Replacement Following Approval of Transcatheter Aortic Valve Replacement For Low-Surgical Risk Patients

  • Author: Ghadi Moubarak, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 11:45 a.m.-12:30 p.m. CST

  • Abstract/Study Purpose: Transcatheter aortic valve replacement (TAVR) was approved in 2019 by the Food and Drug Administration (FDA) for the treatment of aortic stenosis in low surgical risk patients. This study sought to determine the impact of this approval on procedure volume and outcomes for all patients treated by surgical aortic valve replacement (SAVR).

  • For More Information: Click Here

Arrhythmogenic Mitral Annular Disjunction (MAD) Improved Following Mitral Valve Surgery

  • Author: Ingrid Hsiung, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 11:45 a.m.-12:30 p.m. CST

  • Abstract/Study Purpose: Mitral valve prolapse (MVP) and mitral annular disjunction (MAD) have been implicated in ventricular tachycardia (VT) and sudden cardiac death (SCD).

  • For More Information: Click Here

The Road Less Travelled: A Case Series of Percutaneous Transluminal Angioplasty Of Subclavian Artery Stenosis Via Transradial Artery Access

  • Author: Mohammed Salih, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 12:45-1:30 p.m. CST

  • Abstract/Study Purpose: Subclavian artery stenosis (SAS) can present as arm claudication, angina, cerebral hypoperfusion, and digital ischemia. The most common risk factors associated with SAS are hypertension, hyperlipidemia, diabetes, and tobacco use. Traditionally, percutaneous transluminal angioplasty (PTA) with stenting of the SAS is performed via transfemoral access. In this case series, we present a novel method of subclavian artery angioplasty and/or stenting via transradial access.

  • For More Information: Click Here

Valve-In-Valve Transcatheter Mitral-Valve Replacement In A Degenerative Bioprosthetic Valve Exhibiting Stenosis And Regurgitation Complicated By Cardiac Hepatopathy With ECMO Serving As A Bridge To Intervention

  • Author: Mouhamed Nashawi, MD – Baylor Scott & White All Saints Medical Center — Fort Worth

  • Time: 12:45-1:30 p.m. CST

  • Abstract/Study Purpose: Valve-in-valve (ViV) transcutaneous mitral valve repair (TMVR) is an appropriate alternative to surgical mitral valve repair (SMVr). ECMO may facilitate TMVR in high-risk patients exhibiting degenerative bioprosthetic mitral valves (bMV). Factors studied supporting TMVR as safe with less complications relative to SMVr in high-risk patients include tricuspid regurgitation, right-sided heart disease, survival benefit, and cardiogenic shock and hepatopathy outcomes.

  • For More Information: Click Here

A Health Systemwide Collaborative Model To Improve Outcomes Of Transcatheter Aortic Valve Replacement

  • Author: Ghadi Moubarak, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 12:45-1:30 p.m. CST

  • Abstract/Study Purpose: Transcatheter aortic valve replacement (TAVR) has been a disruptive procedure in treating patients with aortic stenosis with variability in procedure performance and patient outcomes. We embarked on a systemwide approach to standardize care processes to improve outcomes by identifying and adopting internal best practices in pre-, intra-, and post-procedural phases of care.

  • For More Information: Click Here

Cardiogenic Shock: Advances, Opportunities, And Controversies Replacement

  • Co-Chair: Shelly Hall, MD – Baylor University Medical Center, part of Baylor Scott & White Health

  • Time: 12:45-2 p.m. CST

  • Summary: This session will present our current understanding and future directions in the evaluation and management of the various categories of cardiogenic shock. Presentations will include pharmacologic and mechanical support strategies and ways to mitigate complications of temporary mechanical cardiac support devices, and current and future clinical trials and progress toward the creation of guidelines.

  • For More Information: Click Here

Drug Coated Balloon Venoplasty to Treat Iatrogenic Pulmonary Vein Stenosis: A Case Series

  • Author: Mohammed Salih, MD – Baylor Scott & White The Heart Hospital – Plano

  • Time: 1:45-1:55 p.m. CST

  • Abstract/Study Purpose: Pulmonary vein stenosis (PVS) post atrial fibrillation (AF) ablation is now rare. The incidence has dramatically decreased from 42.4% in 1999 to 0.5%-4% in recent years. When PVS is associated with mild symptoms, it may respond to conservative management; however, significant symptoms usually require intervention. Transcatheter intervention with Balloon angioplasty (BA) or stenting is an acceptable intervention strategy but is limited by restenosis (72% for BA versus 33% for stenting at 25 months follow-up). Limited data are available for the use of drug coated balloon (DCB). We present four cases of PVS presented after AF ablation procedure, successfully treated with DCB with no restenosis on follow-up supporting that DCB is an effective strategy.

  • For More Information: Click Here

© 2024 Baylor Scott & White Health. All Rights Reserved.
Privacy and Patient Rights Terms of Use Notice of Non-Discrimination
3500 Gaston Ave., Dallas, TX 75246-2017 | 1.844.BSW.DOCS (1.844.279.3627)